In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

Diabetes, Pre-Diabetes and Cardiovascular Diseases developed with the EASD Guidelines

ESC Clinical Practice Guidelines

The emphasis in these Guidelines is to provide information on the current state of the art in how to prevent and manage the diverse problems associated with the effects of DM on the heart and vasculature in a holistic manner.

Diabetes and the Heart
Chronic Nursing Care
Risk Factors and Prevention
Guidelines version available to download
Published in 2013
Reference Eur Heart J 2013;34:3035-3087
Published in 2013
Reference DIABET
Published in 2013
Reference DIABET
Published in 2014
Reference Corrigendum Diabetes
Published in 2013
Reference DIABET
Published in 2013
Reference DIABET
Published in 2013
Reference Slide-set on Diabetes
Published in 2013
Reference DIABET
Table of contents: Full Text (ESC Clinical Practice Guidelines)


  • Introduction
  • Abnormalities of glucose metabolism and CVD
    • Definition, classification and diagnosis, Epidemiology,screening for disorders of glucose metabolism, disorders of glucose mtabolism and CVD, delaying conversion to type 2 diabetes mellitus, recommendations for diagnosis of disorders of glucose metabolism
  • Molecular basis of cardiovascular disease in diabetes mellitus
    • The CV continuum in DM, pathophysiology of insulin resistance in T2DM, endothelial dysfunction - oxidative stress and vascular inflammation, macrophage dysfunction, atherogenic dyslipidaemia, coagulation and platelet function, diabetic cardiomyopathy, the metabolic syndrome, endothelial progenitor cells & vascular repair, conclusions
  • Cardiovascular risk assessment in patients with dysglycaemia
    • risk scores developed for people with DM, evaluation of CV risk in people with pre-diabetes, risk engines developed for people in diabetes, risk assessment based on biomakers and imaging, gaps in knowledge, recommendations for CV risk assessement in diabetes
  • Prevention of CVD in patients with diabetes
    • Lifetsyle, glucose control, blood pressure, dyslipidaemia, platelet function, multifactorials approaches
  • Management of stable & unstable coroary artery disease in patients with diabetes
    • Optimal medical treatment for patients with chronic coronary artery disease and diabetes, revascularization
  • Heart failure and diabetes
    • Prevalence and incidence of HF in T2DM and T2DM in HF, DM and HF morbidity and mortality, pharmacologycal management of HF in T2DM, non-pharmacoloical therapies for HF in DM, glucose lowering treatment in patients with HF, gaps in knowledge, recommendations for management of HF in diabetes
  • Arrhythmias: atrial fibrillation and sudden cardiac death
    • Diabetes mellitus and atrial fibrillation, sudden cardiac death, gaps in knowledge, recommendations for the management of arrhythmias in patients with DM
  • Peripheral- and cerebrovascular disease
    • peripheral artery disease, lower extremity artery disease, carotid artery disease, gaps in knowledge, recommendations for the management of peripheral artery disease in diabetes
  • Microvascular disease in the eyes and kidneys
    • Pathophysiology of microvascular disease, treatment and treatment targets, gaps in knowledge, recommendations for management of microvascular disease in diabetes
  • Patient-centred care
    • General aspects, gaps in knowledge, recommendations for patient-centred care in diabetes
Previous version available to download
Published in 2007
Reference European Heart Journal Supplements (2007) 9 (Supplement C), C3–C74; doi:10.1093/eurheartj/ehl261
Published in 2007
Reference EHJ 2007;28:88-136